Skip to main content

Articles

Page 8 of 8

  1. Unlike glycolytic enzymes that directly catabolize glucose to pyruvate, the family of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFBs) control the conversion of fructose-6-phosphate to and from f...

    Authors: Alden C Klarer, Julie O’Neal, Yoannis Imbert-Fernandez, Amy Clem, Steve R Ellis, Jennifer Clark, Brian Clem, Jason Chesney and Sucheta Telang
    Citation: Cancer & Metabolism 2014 2:2
  2. Cancers cells shift their metabolism towards glycolysis in order to help them support the biosynthetic demands necessary to sustain cell proliferation and growth, adapt to stress and avoid excessive reactive o...

    Authors: Pearl Lee, Karen H Vousden and Eric C Cheung
    Citation: Cancer & Metabolism 2014 2:1
  3. A variety of oncogenic and environmental factors alter tumor metabolism to serve the distinct cellular biosynthetic and bioenergetic needs present during oncogenesis. Extracellular acidosis is a common microen...

    Authors: Gregory LaMonte, Xiaohu Tang, Julia Ling-Yu Chen, Jianli Wu, Chien-Kuang Cornelia Ding, Melissa M Keenan, Carolyn Sangokoya, Hsiu-Ni Kung, Olga Ilkayeva, László G Boros, Christopher B Newgard and Jen-Tsan Chi
    Citation: Cancer & Metabolism 2013 1:23
  4. Glutamine metabolism is a central metabolic pathway in cancer. Recently, reductive carboxylation of glutamine for lipogenesis has been shown to constitute a key anabolic route in cancer cells. However, little ...

    Authors: Shawn McGuirk, Simon-Pierre Gravel, Geneviève Deblois, David J Papadopoli, Brandon Faubert, André Wegner, Karsten Hiller, Daina Avizonis, Uri David Akavia, Russell G Jones, Vincent Giguère and Julie St-Pierre
    Citation: Cancer & Metabolism 2013 1:22
  5. Endocrine FGF21 and FGF19 target adipocytes and hepatocytes through betaKlotho (KLB) and FGFR tyrosine kinases effecting glucose, lipid and energy metabolism. Both factors alleviate obesity and metabolic abnor...

    Authors: Yongde Luo, Chaofeng Yang, Min Ye, Chengliu Jin, James L Abbruzzese, Mong-Hong Lee, Sai-Ching J Yeung and Wallace L McKeehan
    Citation: Cancer & Metabolism 2013 1:21
  6. Although cells require nutrients to proliferate, most nutrient exchange rates of the NCI60 panel of cancer cell lines correlate poorly with their proliferation rate. Here, we provide evidence indicating that t...

    Authors: Sonia C Dolfi, Leo Li-Ying Chan, Jean Qiu, Philip M Tedeschi, Joseph R Bertino, Kim M Hirshfield, Zoltán N Oltvai and Alexei Vazquez
    Citation: Cancer & Metabolism 2013 1:20
  7. Most normal cells in the presence of oxygen utilize glucose for mitochondrial oxidative phosphorylation. In contrast, many cancer cells rapidly convert glucose to lactate in the cytosol, a process termed aerob...

    Authors: Julia Billiard, Jennifer B Dennison, Jacques Briand, Roland S Annan, Deping Chai, Mariela Colón, Christopher S Dodson, Seth A Gilbert, Joel Greshock, Junping Jing, Hong Lu, Jeanelle E McSurdy-Freed, Lisa A Orband-Miller, Gordon B Mills, Chad J Quinn, Jessica L Schneck…
    Citation: Cancer & Metabolism 2013 1:19
  8. Germline and somatic mutations in STK11, the gene encoding the serine/threonine kinase LKB1, are strongly associated with tumorigenesis. While loss of LKB1 expression has been linked to breast cancer, the mechani...

    Authors: Fanny Dupuy, Takla Griss, Julianna Blagih, Gäelle Bridon, Daina Avizonis, Chen Ling, Zhifeng Dong, Doris R Siwak, Matthew G Annis, Gordon B Mills, William J Muller, Peter M Siegel and Russell G Jones
    Citation: Cancer & Metabolism 2013 1:18
  9. The Ets-1 proto-oncogene is frequently upregulated in cancer cells, with known involvement in cancer angiogenesis, metastasis, and more recently energy metabolism. In this study we have performed various bioin...

    Authors: Meghan L Verschoor, Chris P Verschoor and Gurmit Singh
    Citation: Cancer & Metabolism 2013 1:17
  10. The resurgence of interest in cancer metabolism has linked alterations in the regulation and exploitation of metabolic pathways with an anabolic phenotype that increases biomass production for the replication ...

    Authors: Jason A Zastre, Rebecca L Sweet, Bradley S Hanberry and Star Ye
    Citation: Cancer & Metabolism 2013 1:16
  11. Multiple myeloma (MM) is a fatal plasma cell malignancy exhibiting enhanced glucose consumption associated with an aerobic glycolytic phenotype (i.e., the Warburg effect). We have previously demonstrated that ...

    Authors: Javelin C Cheng, Samuel K McBrayer, Cristian Coarfa, Sevim Dalva-Aydemir, Preethi H Gunaratne, John D Carpten, Jonathan K Keats, Steven T Rosen and Mala Shanmugam
    Citation: Cancer & Metabolism 2013 1:14
  12. Loss of function of fumarate hydratase (FH), the mitochondrial tumor suppressor and tricarboxylic acid (TCA) cycle enzyme, is associated with a highly malignant form of papillary and collecting duct renal cell...

    Authors: Liang Zheng, Elaine D MacKenzie, Saadia A Karim, Ann Hedley, Karen Blyth, Gabriela Kalna, David G Watson, Peter Szlosarek, Christian Frezza and Eyal Gottlieb
    Citation: Cancer & Metabolism 2013 1:12
  13. Aerobic glycolysis, namely the Warburg effect, is the main hallmark of cancer cells. Mitochondrial respiratory dysfunction has been proposed to be one of the major causes for such glycolytic shift. This hypoth...

    Authors: Claudia Calabrese, Luisa Iommarini, Ivana Kurelac, Maria Antonietta Calvaruso, Mariantonietta Capristo, Pier-Luigi Lollini, Patrizia Nanni, Christian Bergamini, Giordano Nicoletti, Carla De Giovanni, Anna Ghelli, Valentina Giorgio, Mariano Francesco Caratozzolo, Flaviana Marzano, Caterina Manzari, Christine M Betts…
    Citation: Cancer & Metabolism 2013 1:11
  14. Calorie restriction (CR) is one of the most potent broadly acting dietary interventions for inducing weight loss and for inhibiting cancer in experimental models. Translation of the mechanistic lessons learned...

    Authors: Stephen D Hursting, Sarah M Dunlap, Nikki A Ford, Marcie J Hursting and Laura M Lashinger
    Citation: Cancer & Metabolism 2013 1:10
  15. The p53 tumor suppressor protein is a transcription factor that initiates transcriptional programs aimed at inhibiting carcinogenesis. p53 represses metabolic pathways that support tumor development (such as g...

    Authors: Ido Goldstein, Keren Yizhak, Shalom Madar, Naomi Goldfinger, Eytan Ruppin and Varda Rotter
    Citation: Cancer & Metabolism 2013 1:9
  16. Cancer cells engage in aerobic glycolysis and glutaminolysis to fulfill their biosynthetic and energetic demands in part by activating MYC. Previous reports have characterized metabolic changes in proliferating c...

    Authors: Elena Anso, Andrew R Mullen, Dean W Felsher, José M Matés, Ralph J DeBerardinis and Navdeep S Chandel
    Citation: Cancer & Metabolism 2013 1:7
  17. Metabolic reprogramming is a key event in tumorigenesis to support cell growth, and cancer cells frequently become both highly glycolytic and glutamine dependent. Similarly, T lymphocytes (T cells) modify thei...

    Authors: Andrew N Macintyre and Jeffrey C Rathmell
    Citation: Cancer & Metabolism 2013 1:5
  18. Tissue imaging of treatment-induced metabolic changes is useful for optimizing cancer therapies, but commonly used methods require trade-offs between assay sensitivity and spatial resolution. Nanostructure-Ini...

    Authors: Peter J O’Brien, Michelle Lee, Mary E Spilker, Cathy C Zhang, Zhengming Yan, Timothy C Nichols, Wenlin Li, Caroline H Johnson, Gary J Patti and Gary Siuzdak
    Citation: Cancer & Metabolism 2013 1:4
  19. Regulation of lipid metabolism via activation of sterol regulatory element binding proteins (SREBPs) has emerged as an important function of the Akt/mTORC1 signaling axis. Although the contribution of dysregul...

    Authors: Beatrice Griffiths, Caroline A Lewis, Karim Bensaad, Susana Ros, Qifeng Zhang, Emma C Ferber, Sofia Konisti, Barrie Peck, Heike Miess, Philip East, Michael Wakelam, Adrian L Harris and Almut Schulze
    Citation: Cancer & Metabolism 2013 1:3
  20. While aerobic glycolysis is linked to unconstrained proliferation in cancer, less is known about its physiological role. Why this metabolic program that promotes tumor growth is preserved in the genome has thu...

    Authors: Timothy R Gershon, Andrew J Crowther, Andrey Tikunov, Idoia Garcia, Ryan Annis, Hong Yuan, C Ryan Miller, Jeffrey Macdonald, James Olson and Mohanish Deshmukh
    Citation: Cancer & Metabolism 2013 1:2

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 6.0
    5-year Journal Impact Factor: 5.4
    Source Normalized Impact per Paper (SNIP): N/A
    SCImago Journal Rank (SJR): N/A

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 149

    Usage 2023
    Downloads: 398,435
    Altmetric mentions: 311

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.